تداخل‌های دارویی
Octreotide + Telotristat etiprate
شدت: متوسط
Octreotide and Telotristat etiprate: moderate interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Short-acting octreotide markedly reduces systemic exposure to telotristat and its active metabolite. This may weaken the control of carcinoid syndrome diarrhoea.
معنای این تداخل به زبان ساده
Octreotide and Telotristat etiprate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Octreotide belongs to Endocrine; Telotristat etiprate belongs to Gastrointestinal Tract.
چرا رخ می‌دهد
Octreotide's effects on gastrointestinal function reduce telotristat absorption; the exact mechanism is not fully established.
اقدام لازم
Give short-acting octreotide at least 30 minutes after telotristat. Monitor bowel movement frequency.
از داروساز چه بپرسید
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Octreotide و Telotristat etiprate، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Telotristat etiprate
تداخلات دیگر Octreotide
پرسش‌های متداول
Can I take Octreotide with Telotristat etiprate?
MediHelp rates the interaction as moderate. Octreotide and Telotristat etiprate can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Short-acting octreotide markedly reduces systemic exposure to telotristat and its active metabolite. This may weaken the control of carcinoid syndrome diarrhoea.
How serious is the interaction between Octreotide and Telotristat etiprate?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Give short-acting octreotide at least 30 minutes after telotristat. Monitor bowel movement frequency.
What other medicines interact with Telotristat etiprate?
MediHelp also lists interactions of Telotristat etiprate with, for example, Bupropion, Capecitabine, Everolimus. The full list is on the Telotristat etiprate page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
